Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Early, low-risk International Prognostic Scoring System (IPSS) myelodysplastic syndrome (MDS) is a heterogeneous disorder where the molecular and cellular hematopoietic defects are poorly understood. To gain insight into this condition, we analyzed gene expression profiles of marrow CD34+ progenitor cells from normal-karyotype, low-blast-count MDS patients, age-matched controls, and patients with non-MDS anemia. Given the heterogeneity of early MDS, a surprisingly consistent finding was decreased expression of B-cell lineage-affiliated genes in MDS patients compared with healthy controls and 3 of 5 samples with non-MDS anemia. Both patients with non-MDS anemia with reduced B-cell gene expression were on chemotherapy. In 25 of 27 of the original samples and 9 further MDS samples, Taqman real-time polymerase chain reaction (PCR) confirmed these data. Flow cytometry on unfractionated marrow from independent samples also demonstrated reduced B-cell progenitors in MDS patients compared with healthy controls. These novel findings suggest a common perturbation in early MDS hematopoiesis. They also provide the rationale for a larger study to evaluate the diagnostic utility of reduced B-cell progenitor number as a diagnostic biomarker of early low-risk MDS, which can pose a diagnostic challenge.

Original publication

DOI

10.1182/blood-2005-04-1543

Type

Journal article

Journal

Blood

Publication Date

11/2005

Volume

106

Pages

2982 - 2991

Addresses

Department of Hematology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom OX3 9DU.

Keywords

B-Lymphocytes, Stem Cells, Humans, Myelodysplastic Syndromes, DNA, Complementary, RNA, Messenger, Antigens, CD34, Oligonucleotide Array Sequence Analysis, Risk Factors, Reproducibility of Results, Gene Expression Profiling, Reverse Transcriptase Polymerase Chain Reaction, Computational Biology, Time Factors, Adult, Aged, Aged, 80 and over, Middle Aged, Female, Male